|
Portola Pharmaceuticals
May 22, 2013 - Portola announces pricing of initial public offering
Press Release | Company News
NinePoint
May 16, 2013 - NinePoint Medical Announces U.S. Commercial Availability of the NvisionVLE™ Imaging
System
Press Release | Company News
Alvine
May 14, 2013 - AbbVie and Alvine to Collaborate on Investigational Oral Therapy for Celiac Disease
Press Release | Company News
NinePoint
April 26, 2013 - NinePoint Medical Receives Additional FDA 510(k) Clearance for NvisionVLE Imaging System
Press Release | Company News
Baxano
February 19, 2013 - Baxano Announces Milestone in Clinical Use of iO-Flex® Technology
Press Release | Company News
Portola Pharmaceuticals
February 5, 2013 - Portola Enters Clinical Collaboration Agreement with Bayer and Janssen for Phase 2 Study of PRT4445 and XARELTO
Press Release | Company News
DFine
January 29, 2013 - DFine Announces the launch of StabiliT® ERX, the latest advancement in family of energy-responsive, ultra-high viscosity bone cements
Press Release | Company News
Portola Pharmaceuticals
January 29, 2013 - Portola and Lee’s Pharmaceutical Enter into Agreement to Expand Phase 3 APEX Study of Betrixaban into China
Press Release | Company News
DFine
January 8, 2013 - DFine announces exclusive distribution agreement with Biomet
Press Release | Company News
NGM Biopharmaceuticals
January 3, 2013 - NGM Enters Agreement With Janssen to Discover and Develop Novel Therapeutics for Diabetes
Press Release | Company News
|
